WO2006047198A3 - Composition and method for using a cytokine to treat restenosis - Google Patents
Composition and method for using a cytokine to treat restenosis Download PDFInfo
- Publication number
- WO2006047198A3 WO2006047198A3 PCT/US2005/037684 US2005037684W WO2006047198A3 WO 2006047198 A3 WO2006047198 A3 WO 2006047198A3 US 2005037684 W US2005037684 W US 2005037684W WO 2006047198 A3 WO2006047198 A3 WO 2006047198A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cytokine
- composition
- restenosis
- treat restenosis
- vascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/04—Macromolecular materials
- A61L29/044—Proteins; Polypeptides; Degradation products thereof
- A61L29/048—Other specific proteins or polypeptides not covered by A61L29/045 - A61L29/047
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62248204P | 2004-10-26 | 2004-10-26 | |
US60/622,482 | 2004-10-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006047198A2 WO2006047198A2 (en) | 2006-05-04 |
WO2006047198A3 true WO2006047198A3 (en) | 2007-05-31 |
Family
ID=36228246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/037684 WO2006047198A2 (en) | 2004-10-26 | 2005-10-17 | Composition and method for using a cytokine to treat restenosis |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006047198A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020090388A1 (en) * | 2000-12-01 | 2002-07-11 | Humes H. David | Intravascular drug delivery device and use therefor |
US20020128599A1 (en) * | 2000-10-26 | 2002-09-12 | Cormier Michel J.N. | Transdermal drug delivery devices having coated microprotrusions |
-
2005
- 2005-10-17 WO PCT/US2005/037684 patent/WO2006047198A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020128599A1 (en) * | 2000-10-26 | 2002-09-12 | Cormier Michel J.N. | Transdermal drug delivery devices having coated microprotrusions |
US20020090388A1 (en) * | 2000-12-01 | 2002-07-11 | Humes H. David | Intravascular drug delivery device and use therefor |
Also Published As
Publication number | Publication date |
---|---|
WO2006047198A2 (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006014270A3 (en) | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders | |
WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
WO2009148926A3 (en) | Biosoluble coating comprising anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders | |
WO2004060318A3 (en) | Drug-coated stents and methods of use therefor | |
WO2006023649A3 (en) | Treatment of severe multiple sclerosis | |
WO2005027842A3 (en) | Combinations of drugs for the treatment of neoplasms | |
MXPA04006731A (en) | Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof. | |
WO2005011734A3 (en) | Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer | |
WO2004069201A3 (en) | Compounds useful in coating stents to prevent and treat stenosis and restenosis | |
WO2006002399A3 (en) | Biodegradable implantable medical devices, methods and systems | |
EP1811923A4 (en) | Stepped balloon catheter for treating vascular bifurcations | |
WO2006024018A3 (en) | Compositions for treating nociceptive pain | |
EP1635815A4 (en) | Methods and compounds for the treatment of vascular stenosis | |
WO2006055871A3 (en) | Treatment for multiple sclerosis | |
WO2002078684A3 (en) | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders | |
DK0786991T3 (en) | Polyamine Compounds for the Treatment of Proliferative Vascular Diseases | |
WO2007047919A3 (en) | Treatment of restenosis and stenosis with dasatinib | |
EP1642592A4 (en) | Remedy for sarcoidosis and method of treating the same | |
WO2004098495A3 (en) | Medical devices and methods for inhibiting proliferation of smooth muscle cells | |
WO2007087424A3 (en) | Method of treating kcnq related disorders using organozinc compounds | |
WO2005011572A3 (en) | Combination of drugs for the treatment of neoplasms | |
EP1744761A4 (en) | Methods for treating or preventing restenosis and other vascular proliferative disorders | |
WO2004009773A3 (en) | Methods and compositions for activating or inhibiting vegf-d and vegf-c | |
WO2010042343A3 (en) | Combination local delivery using a stent | |
WO2004060444A3 (en) | Device for maintaining catheter lumen patency |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV LY MD MG MK MN MW MX MZ NA NG NO NZ OM PG PH PL PT RO RU SC SD SG SK SL SM SY TJ TM TN TR TT TZ UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IS IT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05817062 Country of ref document: EP Kind code of ref document: A2 |